title: Metastatic melanoma to the thyroid gland expressing somatostatin receptors-imaging with 68Ga-DOTANOC PET/CT.
abstract: Malignant melanoma is an aggressive tumor with poor prognosis that can have widespread metastases at presentation. Melanoma is known to undergo neuroendocrine differentiation. We report a case of a 60-year-old woman with malignant melanoma showing a metastatic lesion in the thyroid expressing somatostatin receptors as evident by Ga-DOTANOC PET/CT and metabolically active widespread subcutaneous metastases on F-FDG PET/CT imaging.
authors.affiliation: From the Departments of *Nuclear Medicine & PET, †Histopathology, ‡Cytology & Gynaecological Pathology, and §Radiotherapy, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
authors.forename: Rayamajhi Sampanna
authors.initials: RS
authors.lastname: Jung
authors.forename: Bhagwant Rai
authors.initials: BR
authors.lastname: Mittal
authors.forename: Amanjit
authors.initials: A
authors.lastname: Bal
authors.forename: Pranab
authors.initials: P
authors.lastname: Dey
authors.forename: Jaya
authors.initials: J
authors.lastname: Shukla
authors.forename: Rakesh
authors.initials: R
authors.lastname: Kapoor
mesh_terms: D005260:Female; D006801:Humans; D008545:Melanoma / Q000000981:diagnostic imaging* / Q000473:pathology; D008875:Middle Aged; D064847:Multimodal Imaging; D009942:Organometallic Compounds; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D014057:Tomography, X-Ray Computed
chemical_list: C504894:68Ga-DOTANOC; D009942:Organometallic Compounds; D019275:Radiopharmaceuticals